Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers

Author： Cacciottolo Mafalda   Nogalska Anna   D’Agostino Carla   Engel W.   Askanas Valerie  

Publisher： Springer Publishing Company

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.126, Iss.5, 2013-11, pp. : 781-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Increased plasma amyloid-β 42 protein in sporadic inclusion body myositis

By Abdo Wilson  

Acta Neuropathologica, Vol. 118, Iss. 3, 2009-09 ,pp. : 429-431

Springer Publishing Company

Access to resources Recommend Favorite

p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis

By Nogalska Anna  

Acta Neuropathologica, Vol. 118, Iss. 3, 2009-09 ,pp. : 407-413

Springer Publishing Company

Access to resources Recommend Favorite

Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis

By Sancricca Cristina  

Neurological Sciences, Vol. 32, Iss. 5, 2011-10 ,pp. : 841-847

Springer Publishing Company

Access to resources Recommend Favorite

Update on sporadic inclusion body myositis

By Hohlfeld Reinhard  

Brain, Vol. 134, Iss. 11, 2011-11 ,pp. : 3141-3145

Oxford University Press

Access to resources Recommend Favorite

Amyloid β Peptide Levels Increase in Brain of AβPP Swedish Mice after Exposure to Chlorpyrifos

By  

Current Alzheimer Research, Vol. 8, Iss. 7, 2011-11 ,pp. : 732-740

Bentham Science Publishers

Access to resources Recommend Favorite